1
Avdoralimab an Anti-C5aR Antibody, in Patients With COVID-19 Severe Pneumonia ( FORCE )
Condition(s):COVIDLast Updated:May 27, 2021Completed
Hide Studies Not Open or Pending
Condition(s):COVIDLast Updated:May 27, 2021Completed
Condition(s):Bullous PemphigoidLast Updated:September 6, 2023Active, not recruiting
Condition(s):SARS-CoV-2 (COVID-19) Infection; Advanced or Metastatic Hematological or Solid TumorLast Updated:September 30, 2022Completed
Condition(s):Advanced Solid TumorsLast Updated:January 27, 2022Terminated
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.